GeoVax Labs Warrants
GOVXW
GOVXW was delisted on the 26th of September, 2025.
2 hedge funds and large institutions have $15K invested in GeoVax Labs Warrants in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
17% more capital invested
Capital invested by funds: $12.8K → $15K (+$2.13K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.64K |
GOVXW Hedge Fund Activity: Q1 2023 in Review
2 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs Warrants (GOVXW) for Q1 2023, worth a combined $15K — up 17% from $12.8K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GOVXW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $23. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.64K sold.
- 2 institutional investors held GeoVax Labs Warrants (GOVXW) as of Q1 2023, down from 3 in Q4 2022.
- Funds reported $15K of GeoVax Labs Warrants stock for Q1 2023, up 17% quarter-over-quarter.
- 0 funds opened new GeoVax Labs Warrants positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest GeoVax Labs Warrants buyer in Q1 2023 was UBS Group, an estimated $23 added.
- The largest GeoVax Labs Warrants seller in Q1 2023 was Susquehanna International Group, an estimated $2.64K sold.
Based on aggregated 13F filings for Q1 2023.